Medicure (MCUJF) Liabilities from Discontinued Operations (2017)
Medicure's (MCUJF) quarterly Liabilities from Discontinued Operations came in at 5491350.7 in Q4 2017, down 86.33% quarter-over-quarter from 40168076.37 in Q3 2017.
Medicure (MCUJF) Liabilities from Discontinued Operations (2017) Analysis & Trends
Medicure's Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 5491350.7 for Q4 2017.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to 5491350.7 in Q4 2017; TTM through Dec 2017 was 5491350.7, a N/A change from a year earlier, with the FY2017 full-year figure at 5377355.95, changed N/A from the prior year.
- Liabilities from Discontinued Operations retreated to 5491350.7 in Q4 2017 per MCUJF's latest filing, from 40168076.37 in the prior quarter.
- Across five years, Liabilities from Discontinued Operations topped out at 40168076.37 in Q3 2017 and bottomed at 5491350.7 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 5.49 Mn |
| Dec 31, 2017 | 5.49 Mn |
| Sep 30, 2017 | 40.17 Mn |
| Sep 30, 2017 | 40.17 Mn |